| C070379 | 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester | "1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [EGF protein affects the localization of PRKCB protein]" | 17991733 |
| C029705 | 12-deoxyphorbolphenylacetate-20-acetate | 12-deoxyphorbolphenylacetate-20-acetate affects the localization of PRKCB protein | 9852137 |
| C049325 | 1,2-dithiol-3-thione | "1,2-dithiol-3-thione results in decreased expression of PRKCB mRNA" | 19162173 |
| C023514 | 2,6-dinitrotoluene | "2,6-dinitrotoluene affects the expression of PRKCB mRNA" | 21346803 |
| C030370 | 2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone | "2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone results in decreased expression of PRKCB mRNA" | 20206263 |
| C572491 | 3-(2-hydroxy-4-(2-methylnonan-2-yl)phenyl)cyclohexan-1-ol | 3-(2-hydroxy-4-(2-methylnonan-2-yl)phenyl)cyclohexan-1-ol results in increased expression of PRKCB protein | 26194647 |
| C500067 | 3-((5-(6-((3-chlorophenyl)amino)pyrazinyl)-3-pyridinyl)amino)-1-propanol | 3-((5-(6-((3-chlorophenyl)amino)pyrazinyl)-3-pyridinyl)amino)-1-propanol binds to and results in decreased activity of PRKCB protein | 15771433 |
| C009505 | 4,4'-diaminodiphenylmethane | "4,4'-diaminodiphenylmethane results in increased expression of PRKCB mRNA" | 25380136 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRKCB mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PRKCB mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRKCB mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PRKCB mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PRKCB mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRKCB mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRKCB mRNA" | 27188386 |
| C434605 | 5,21 - 12,17-dimetheneo-18H-dibenzo(i,o)pyrrolo(3,4-1)(1,8)diazacyclohexandecine-18,10(19H)dione,8((dimethylamino)methyl)-6,7,8,9,10,11-hexahydro,monomethanesulfonate | "5,21 - 12,17-dimetheneo-18H-dibenzo(i,o)pyrrolo(3,4-1)(1,8)diazacyclohexandecine-18,10(19H)dione,8((dimethylamino)methyl)-6,7,8,9,10,11-hexahydro,monomethanesulfonate inhibits the reaction [Glucose results in increased expression of PRKCB protein]" | 16285992 |
| C434605 | 5,21 - 12,17-dimetheneo-18H-dibenzo(i,o)pyrrolo(3,4-1)(1,8)diazacyclohexandecine-18,10(19H)dione,8((dimethylamino)methyl)-6,7,8,9,10,11-hexahydro,monomethanesulfonate | "5,21 - 12,17-dimetheneo-18H-dibenzo(i,o)pyrrolo(3,4-1)(1,8)diazacyclohexandecine-18,10(19H)dione,8((dimethylamino)methyl)-6,7,8,9,10,11-hexahydro,monomethanesulfonate inhibits the reaction [Glucose results in increased expression of PRKCB protein alternative form]" | 16285992 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRKCB mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PRKCB mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRKCB mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PRKCB mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PRKCB mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRKCB mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRKCB mRNA" | 27188386 |
| D000079 | Acetaldehyde | PRKCB protein affects the reaction [EGF protein inhibits the reaction [Acetaldehyde results in increased transport of Inulin]] | 17991733 |
| D000079 | Acetaldehyde | PRKCB protein affects the reaction [EGF protein results in decreased susceptibility to Acetaldehyde] | 17991733 |
| D000082 | Acetaminophen | Acetaminophen results in increased expression of PRKCB mRNA | 21420995 |
| D000082 | Acetaminophen | Acetaminophen affects the expression of PRKCB mRNA | 17562736 |
| D000082 | Acetaminophen | Acetaminophen results in increased expression of PRKCB mRNA | 15120968 |
| D020106 | Acrylamide | Acrylamide affects the expression of PRKCB mRNA | 28959563 |
| D000517 | alpha-Chlorohydrin | alpha-Chlorohydrin results in decreased expression of PRKCB mRNA | 20409345 |
| C011512 | alpha-naphthoflavone | alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin affects the localization of PRKCB protein] | 16797713 |
| C011512 | alpha-naphthoflavone | alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased localization of PRKCB protein] | 17222441 |
| D000535 | Aluminum | [APP protein modified form binds to Aluminum] which results in decreased expression of PRKCB mRNA | 21298039 |
| D000643 | Ammonium Chloride | Ammonium Chloride affects the expression of PRKCB mRNA | 16483693 |
| D000643 | Ammonium Chloride | Ammonium Chloride results in decreased expression of PRKCB protein | 16483693 |
| D000661 | Amphetamine | Amphetamine affects the expression of PRKCB mRNA | 16101753 |
| D018501 | Antirheumatic Agents | Antirheumatic Agents results in decreased expression of PRKCB mRNA | 24449571 |
| D001151 | Arsenic | Arsenic affects the methylation of PRKCB gene | 25304211 |
| C006632 | arsenic trioxide | arsenic trioxide results in decreased expression of PRKCB mRNA | 15725085 |
| C006632 | arsenic trioxide | arsenic trioxide results in increased expression of PRKCB mRNA | 10673743 |
| C006632 | arsenic trioxide | PRKCB mRNA affects the susceptibility to arsenic trioxide | 23911876 |
| C006632 | arsenic trioxide | Tretinoin promotes the reaction [arsenic trioxide results in increased expression of PRKCB mRNA] | 10673743 |
| C015001 | arsenite | arsenite results in decreased expression of PRKCB mRNA | 18191166 |
| D001205 | Ascorbic Acid | Ascorbic Acid results in increased expression of PRKCB mRNA | 15305145 |
| D001241 | Aspirin | Aspirin affects the expression of PRKCB protein | 17644113 |
| D001241 | Aspirin | Aspirin inhibits the reaction [Deoxycholic Acid results in increased expression of PRKCB protein] | 17644113 |
| D001397 | Azoxymethane | Azoxymethane results in increased phosphorylation of and results in increased activity of PRKCB protein | 21355597 |
| D001397 | Azoxymethane | pterostilbene inhibits the reaction [Azoxymethane results in increased phosphorylation of and results in increased activity of PRKCB protein] | 21355597 |
| C030935 | benz(a)anthracene | benz(a)anthracene results in increased expression of PRKCB mRNA | 26377693 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene metabolite results in increased expression of PRKCB mRNA | 26314263 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in decreased expression of PRKCB mRNA | 20064835 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in decreased expression of PRKCB mRNA | 21569818 |
| C090535 | benzyloxycarbonyl-isoleucyl-glutamyl(O-tert-butyl)-alanyl-leucinal | benzyloxycarbonyl-isoleucyl-glutamyl(O-tert-butyl)-alanyl-leucinal inhibits the reaction [Deoxycholic Acid results in increased expression of PRKCB protein] | 17644113 |
| C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Deoxycholic Acid results in increased expression of PRKCB protein] | 17644113 |
| D004958 | Estradiol | Estradiol results in decreased expression of PRKCB mRNA | 20068009 |
| C070515 | bisindolylmaleimide I | bisindolylmaleimide I inhibits the reaction [Glucose results in increased expression of PRKCB protein] | 16285992 |
| C070515 | bisindolylmaleimide I | bisindolylmaleimide I inhibits the reaction [Glucose results in increased expression of PRKCB protein alternative form] | 16285992 |
| C006780 | bisphenol A | bisphenol A affects the expression of PRKCB mRNA | 25181051 |
| C005961 | bis(tri-n-butyltin)oxide | bis(tri-n-butyltin)oxide results in increased expression of PRKCB mRNA | 26314263 |
| C046785 | bryostatin 1 | [bryostatin 1 co-treated with mezerein] results in decreased expression of PRKCB protein | 8892972 |
| C046785 | bryostatin 1 | [bryostatin 1 co-treated with mezerein] results in decreased expression of PRKCB protein alternative form | 8892972 |
| C046785 | bryostatin 1 | bryostatin 1 results in decreased expression of PRKCB protein | 8892972 |
| C046785 | bryostatin 1 | bryostatin 1 results in decreased expression of PRKCB protein alternative form | 8892972 |
| D002045 | Bupivacaine | [Bupivacaine co-treated with Tetrodotoxin co-treated with Dexamethasone] results in decreased expression of PRKCB mRNA | 22341215 |
| D020001 | 1-Butanol | 1-Butanol affects the localization of PRKCB protein | 15067001 |
| D020001 | 1-Butanol | 1-Butanol inhibits the reaction [Thapsigargin results in increased localization of PRKCB protein] | 15843515 |
| D019328 | Buthionine Sulfoximine | Buthionine Sulfoximine results in decreased activity of PRKCB protein | 11118818 |
| C018475 | butyraldehyde | butyraldehyde results in increased expression of PRKCB mRNA | 26079696 |
| D002087 | Butyrates | Butyrates results in increased expression of PRKCB protein | 15471852 |
| D019256 | Cadmium Chloride | Cadmium Chloride results in decreased expression of PRKCB mRNA | 25993096 |
| D019256 | Cadmium Chloride | Cadmium Chloride results in decreased expression of PRKCB protein | 27389774 |
| D019256 | Cadmium Chloride | Quercetin inhibits the reaction [Cadmium Chloride results in decreased expression of PRKCB protein] | 27389774 |
| D002118 | Calcium | Calcium inhibits the reaction [Chlordecone results in increased activity of PRKCB protein] | 1724372 |
| D002118 | Calcium | Calcium inhibits the reaction [Dicofol results in increased activity of PRKCB protein] | 1724372 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in increased expression of PRKCB mRNA | 27339419 |
| D007631 | Chlordecone | Calcium inhibits the reaction [Chlordecone results in increased activity of PRKCB protein] | 1724372 |
| D007631 | Chlordecone | Chlordecone results in increased activity of PRKCB protein | 1724372 |
| D007631 | Chlordecone | Phosphatidylserines promotes the reaction [Chlordecone results in increased activity of PRKCB protein] | 1724372 |
| D020111 | Chlorodiphenyl (54% Chlorine) | Chlorodiphenyl (54% Chlorine) results in decreased expression of PRKCB mRNA | 23650126 |
| D020245 | p-Chloromercuribenzoic Acid | "[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PRKCB mRNA" | 27188386 |
| D020245 | p-Chloromercuribenzoic Acid | p-Chloromercuribenzoic Acid results in decreased expression of PRKCB mRNA | 26272509 |
| D002737 | Chloroprene | Chloroprene results in decreased expression of PRKCB mRNA | 23125180 |
| D004390 | Chlorpyrifos | Chlorpyrifos results in increased expression of PRKCB mRNA | 19368821 |
| D002794 | Choline | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of PRKCB | 20938992 |
| D002794 | Choline | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of PRKCB gene | 20938992 |
| D002794 | Choline | Choline affects the expression of PRKCB mRNA | 17264169 |
| D002794 | Choline | Choline affects the expression of PRKCB protein | 17264169 |
| C055162 | clopidogrel | clopidogrel inhibits the reaction [Lipopolysaccharides results in increased expression of PRKCB mRNA] | 19172522 |
| D003024 | Clozapine | Clozapine affects the expression of PRKCB protein | 15967061 |
| D003024 | Clozapine | Clozapine results in increased expression of PRKCB mRNA | 15860345 |
| D060729 | Coal Ash | Coal Ash results in decreased expression of PRKCB mRNA | 19000753 |
| C018021 | cobaltous chloride | cobaltous chloride results in increased oxidation of and results in increased activity of PRKCB protein | 18375950 |
| D003042 | Cocaine | Cocaine results in decreased expression of PRKCB mRNA | 12629581 |
| D003042 | Cocaine | Cocaine results in increased expression of PRKCB mRNA | 17898221 |
| D016578 | Crack Cocaine | Crack Cocaine results in increased expression of PRKCB mRNA | 12629581 |
| D003513 | Cycloheximide | Cycloheximide results in decreased expression of PRKCB mRNA | 19684285 |
| D003513 | Cycloheximide | [Tetrachlorodibenzodioxin co-treated with Cycloheximide] results in increased expression of PRKCB mRNA | 19684285 |
| D016572 | Cyclosporine | Cyclosporine results in increased expression of PRKCB protein | 22155090 |
| C004742 | daidzein | daidzein results in increased activity of PRKCB protein | 16972265 |
| C014347 | decitabine | decitabine affects the expression of PRKCB mRNA | 23300844 |
| D003840 | Deoxycholic Acid | Aspirin inhibits the reaction [Deoxycholic Acid results in increased expression of PRKCB protein] | 17644113 |
| D003840 | Deoxycholic Acid | benzyloxycarbonyl-isoleucyl-glutamyl(O-tert-butyl)-alanyl-leucinal inhibits the reaction [Deoxycholic Acid results in increased expression of PRKCB protein] | 17644113 |
| D003840 | Deoxycholic Acid | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Deoxycholic Acid results in increased expression of PRKCB protein] | 17644113 |
| D003840 | Deoxycholic Acid | Deoxycholic Acid results in increased activity of PRKCB protein | 7705931 |
| D003840 | Deoxycholic Acid | Deoxycholic Acid results in increased expression of PRKCB protein | 17644113 |
| D003840 | Deoxycholic Acid | lactacystin inhibits the reaction [Deoxycholic Acid results in increased expression of PRKCB protein] | 17644113 |
| D003907 | Dexamethasone | [Bupivacaine co-treated with Tetrodotoxin co-treated with Dexamethasone] results in decreased expression of PRKCB mRNA | 22341215 |
| D002945 | Cisplatin | Cisplatin affects the expression of PRKCB mRNA | 23300844 |
| D002945 | Cisplatin | Cisplatin results in decreased expression of PRKCB mRNA | 22023808 |
| D004010 | Dicofol | Calcium inhibits the reaction [Dicofol results in increased activity of PRKCB protein] | 1724372 |
| D004010 | Dicofol | Dicofol results in increased activity of PRKCB protein | 1724372 |
| D004010 | Dicofol | Phosphatidylserines promotes the reaction [Dicofol results in increased activity of PRKCB protein] | 1724372 |
| D004052 | Diethylnitrosamine | Diethylnitrosamine results in increased phosphorylation of and results in increased activity of PRKCB protein | 17942915 |
| D004052 | Diethylnitrosamine | MET protein inhibits the reaction [Diethylnitrosamine results in increased phosphorylation of and results in increased activity of PRKCB protein] | 17942915 |
| D004054 | Diethylstilbestrol | Diethylstilbestrol results in increased expression of PRKCB mRNA | 16636312 |
| D004054 | Diethylstilbestrol | Diethylstilbestrol results in increased expression of PRKCB mRNA | 17005392 |
| D015127 | 9,10-Dimethyl-1,2-benzanthracene | "PRKCB protein inhibits the reaction [CYP1B1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]" | 10037446 |
| D015127 | 9,10-Dimethyl-1,2-benzanthracene | "PRKCB protein inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [CYP1B1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]]" | 10037446 |
| D004128 | Dimethylnitrosamine | Dimethylnitrosamine results in increased expression of PRKCB mRNA | 25380136 |
| D004137 | Dinitrochlorobenzene | Dinitrochlorobenzene affects the localization of PRKCB protein | 24136171 |
| D004237 | Diuron | Diuron results in increased expression of PRKCB mRNA | 21551480 |
| C067311 | docetaxel | docetaxel results in increased phosphorylation of PRKCB protein | 25634538 |
| C067311 | docetaxel | sotrastaurin inhibits the reaction [docetaxel results in increased phosphorylation of PRKCB protein] | 25634538 |
| D004317 | Doxorubicin | Doxorubicin results in decreased expression of PRKCB mRNA | 25896364 |
| D004317 | Doxorubicin | Doxorubicin results in increased phosphorylation of PRKCB protein | 26318906 |
| C118739 | entinostat | entinostat results in increased expression of PRKCB mRNA | 26272509|2718838 |
| C118739 | entinostat | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRKCB mRNA" | 27188386 |
| D000431 | Ethanol | [Ethanol results in increased localization of and results in increased activity of PRKCB protein] promotes the reaction [Tetradecanoylphorbol Acetate results in increased abundance of Superoxides] | 10651808 |
| D000431 | Ethanol | Ethanol results in increased expression of and results in increased activity of PRKCB protein | 22497828 |
| D000431 | Ethanol | Ethanol results in increased expression of PRKCB protein | 22497828 |
| D000431 | Ethanol | Losartan inhibits the reaction [Ethanol results in increased expression of PRKCB protein] | 22497828 |
| D000431 | Ethanol | PRKCB protein affects the reaction [Ethanol results in increased cleavage of and results in increased activity of CASP3 protein] | 22497828 |
| D000431 | Ethanol | PRKCB protein affects the reaction [Ethanol results in increased expression of NCF1 protein] | 22497828 |
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in increased expression of PRKCB mRNA | 17351261 |
| C559943 | ethyl-1-(4-(2*3*3-trichloroacrylamide)phenyl)-5-(trifluoromethyl)-1H-pyrazole-4-carboxylate | ethyl-1-(4-(2*3*3-trichloroacrylamide)phenyl)-5-(trifluoromethyl)-1H-pyrazole-4-carboxylate inhibits the reaction [Zeranol results in increased phosphorylation of PRKCB protein] | 27224899 |
| D005020 | Ethyl Methanesulfonate | Ethyl Methanesulfonate results in decreased expression of PRKCB mRNA | 23649840 |
| C054207 | etomoxir | etomoxir results in increased expression of PRKCB mRNA | 19234235 |
| D005419 | Flavonoids | Flavonoids results in decreased expression of PRKCB mRNA | 18035473 |
| D016666 | Fluvoxamine | [Haloperidol co-treated with Fluvoxamine] affects the expression of PRKCB protein | 15967061 |
| D005492 | Folic Acid | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of PRKCB | 20938992 |
| D005492 | Folic Acid | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of PRKCB gene | 20938992 |
| D005557 | Formaldehyde | Formaldehyde results in decreased expression of PRKCB mRNA | 23649840 |
| C039281 | furan | furan results in decreased expression of PRKCB mRNA | 15120968 |
| C039281 | furan | furan results in increased methylation of PRKCB gene | 22079235 |
| D005839 | Gentamicins | Gentamicins results in increased expression of PRKCB mRNA | 22061828 |
| D005947 | Glucose | "5,21 - 12,17-dimetheneo-18H-dibenzo(i,o)pyrrolo(3,4-1)(1,8)diazacyclohexandecine-18,10(19H)dione,8((dimethylamino)methyl)-6,7,8,9,10,11-hexahydro,monomethanesulfonate inhibits the reaction [Glucose results in increased expression of PRKCB protein]" | 16285992 |
| D005947 | Glucose | "5,21 - 12,17-dimetheneo-18H-dibenzo(i,o)pyrrolo(3,4-1)(1,8)diazacyclohexandecine-18,10(19H)dione,8((dimethylamino)methyl)-6,7,8,9,10,11-hexahydro,monomethanesulfonate inhibits the reaction [Glucose results in increased expression of PRKCB protein alternative form]" | 16285992 |
| D005947 | Glucose | bisindolylmaleimide I inhibits the reaction [Glucose results in increased expression of PRKCB protein] | 16285992 |
| D005947 | Glucose | bisindolylmaleimide I inhibits the reaction [Glucose results in increased expression of PRKCB protein alternative form] | 16285992 |
| D005947 | Glucose | Glucose results in increased activity of PRKCB protein | 20578705 |
| D005947 | Glucose | Glucose results in increased expression of PRKCB protein | 16285992 |
| D005947 | Glucose | Glucose results in increased expression of PRKCB protein alternative form | 16285992 |
| D005947 | Glucose | Glucose results in increased phosphorylation of PRKCB protein | 22162761 |
| D005947 | Glucose | manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Glucose results in increased expression of PRKCB protein] | 16285992 |
| D005947 | Glucose | manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Glucose results in increased expression of PRKCB protein alternative form] | 16285992 |
| D005947 | Glucose | Mannitol inhibits the reaction [Glucose results in increased expression of PRKCB protein] | 16285992 |
| D005947 | Glucose | Mannitol inhibits the reaction [Glucose results in increased expression of PRKCB protein alternative form] | 16285992 |
| D005947 | Glucose | resveratrol inhibits the reaction [Glucose results in increased activity of PRKCB protein] | 20578705 |
| D005947 | Glucose | Thenoyltrifluoroacetone inhibits the reaction [Glucose results in increased expression of PRKCB protein] | 16285992 |
| D005947 | Glucose | Thenoyltrifluoroacetone inhibits the reaction [Glucose results in increased expression of PRKCB protein alternative form] | 16285992 |
| D005947 | Glucose | Glucose results in increased phosphorylation of and results in increased activity of PRKCB protein | 19587355 |
| D005947 | Glucose | PRKCB protein affects the reaction [Glucose results in increased activity of RELA protein] | 19587355 |
| D005947 | Glucose | PRKCB protein affects the reaction [Glucose results in increased expression of NOS2 protein] | 19587355 |
| D005947 | Glucose | PRKCB protein affects the reaction [Glucose results in increased phosphorylation of and results in increased activity of MAPK1 protein] | 19587355 |
| D005947 | Glucose | PRKCB protein affects the reaction [Glucose results in increased phosphorylation of and results in increased activity of MAPK3 protein] | 19587355 |
| D005947 | Glucose | ruboxistaurin inhibits the reaction [Glucose results in increased phosphorylation of and results in increased activity of PRKCB protein] | 19587355 |
| C081021 | Go 6976 | Go 6976 results in decreased activity of PRKCB protein | 15767308 |
| C508665 | gold (III) porphyrin 1a | gold (III) porphyrin 1a results in decreased expression of PRKCB mRNA | 16206274 |
| D006220 | Haloperidol | [Haloperidol co-treated with Fluvoxamine] affects the expression of PRKCB protein | 15967061 |
| D006220 | Haloperidol | Haloperidol results in increased expression of PRKCB mRNA | 15860345 |
| C007946 | hispidin | hispidin results in decreased activity of PRKCB protein | 16374459 |
| D017313 | Fenretinide | Fenretinide results in increased expression of PRKCB mRNA | 28973697 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide affects the localization of and results in increased activity of PRKCB protein | 12821678 |
| D007213 | Indomethacin | Indomethacin results in decreased expression of PRKCB protein alternative form | 10702201 |
| D007213 | Indomethacin | Indomethacin results in increased expression of PRKCB protein alternative form | 10702201 |
| D007213 | Indomethacin | PRKCB protein alternative form results in decreased susceptibility to Indomethacin | 10702201 |
| D007444 | Inulin | PRKCB protein affects the reaction [EGF protein inhibits the reaction [Acetaldehyde results in increased transport of Inulin]] | 17991733 |
| D015759 | Ionomycin | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of PRKCB mRNA | 25613284 |
| C051890 | irinotecan | irinotecan metabolite results in increased phosphorylation of PRKCB protein | 15723263 |
| C051890 | irinotecan | irinotecan results in increased phosphorylation of PRKCB protein | 15723263 |
| D007545 | Isoproterenol | Isoproterenol results in decreased expression of PRKCB mRNA | 21335049 |
| C561695 | (+)-JQ1 compound | (+)-JQ1 compound results in decreased expression of PRKCB mRNA | 23086925|2725927 |
| C067713 | lactacystin | lactacystin inhibits the reaction [Deoxycholic Acid results in increased expression of PRKCB protein] | 17644113 |
| D007854 | Lead | Lead affects the expression of PRKCB mRNA | 28903495 |
| D007854 | Lead | Lead results in decreased expression of PRKCB protein | 16547843 |
| C008261 | lead acetate | lead acetate results in decreased expression of PRKCB protein | 16547843 |
| C045463 | leflunomide | leflunomide results in increased expression of PRKCB mRNA | 28988120 |
| D008070 | Lipopolysaccharides | clopidogrel inhibits the reaction [Lipopolysaccharides results in increased expression of PRKCB mRNA] | 19172522 |
| D008095 | Lithocholic Acid | Lithocholic Acid results in increased activity of PRKCB protein | 7705931 |
| D019808 | Losartan | Losartan inhibits the reaction [Ethanol results in increased expression of PRKCB protein] | 22497828 |
| C018091 | maduramicin | maduramicin results in decreased expression of PRKCB mRNA | 29128925 |
| D058185 | Magnetite Nanoparticles | [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PRKCB mRNA | 26378955 |
| C097284 | manganese(III)-tetrakis(4-benzoic acid)porphyrin | manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Glucose results in increased expression of PRKCB protein] | 16285992 |
| C097284 | manganese(III)-tetrakis(4-benzoic acid)porphyrin | manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Glucose results in increased expression of PRKCB protein alternative form] | 16285992 |
| D008353 | Mannitol | Mannitol inhibits the reaction [Glucose results in increased expression of PRKCB protein] | 16285992 |
| D008353 | Mannitol | Mannitol inhibits the reaction [Glucose results in increased expression of PRKCB protein alternative form] | 16285992 |
| C042720 | mercuric bromide | mercuric bromide results in decreased expression of PRKCB mRNA | 26272509 |
| C042720 | mercuric bromide | "[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PRKCB mRNA" | 27188386 |
| D008687 | Metformin | Metformin results in decreased expression of PRKCB mRNA | 15531508 |
| D008687 | Metformin | Metformin results in decreased expression of PRKCB protein | 15531508 |
| D008701 | Methapyrilene | Methapyrilene results in decreased expression of PRKCB mRNA | 15120968 |
| D008715 | Methionine | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of PRKCB | 20938992 |
| D008715 | Methionine | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of PRKCB gene | 20938992 |
| D008727 | Methotrexate | Methotrexate results in increased expression of PRKCB mRNA | 15120968 |
| D008731 | Methoxychlor | Methoxychlor results in decreased expression of PRKCB mRNA | 23303685 |
| D008731 | Methoxychlor | Methoxychlor results in increased methylation of PRKCB gene | 23303685 |
| C004925 | methylmercuric chloride | methylmercuric chloride affects the expression of PRKCB protein | 27012723 |
| C004925 | methylmercuric chloride | methylmercuric chloride results in decreased expression of PRKCB mRNA | 28001369 |
| D008741 | Methyl Methanesulfonate | Methyl Methanesulfonate results in decreased expression of PRKCB mRNA | 23649840 |
| D018817 | N-Methyl-3,4-methylenedioxyamphetamine | "N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of PRKCB mRNA" | 19285098|2018815 |
| C008493 | methylselenic acid | methylselenic acid results in increased expression of PRKCB mRNA | 18548127 |
| C011309 | mezerein | [bryostatin 1 co-treated with mezerein] results in decreased expression of PRKCB protein | 8892972 |
| C011309 | mezerein | [bryostatin 1 co-treated with mezerein] results in decreased expression of PRKCB protein alternative form | 8892972 |
| C059539 | midostaurin | midostaurin results in decreased activity of PRKCB protein | 15542774 |
| C070571 | ML 7 | ML 7 results in decreased expression of PRKCB protein | 17272349 |
| D009020 | Morphine | HINT1 gene mutant form inhibits the reaction [Morphine promotes the reaction [OPRM1 protein binds to PRKCB protein]] | 18652891 |
| D009020 | Morphine | Morphine promotes the reaction [OPRM1 protein binds to PRKCB protein] | 18652891 |
| D009151 | Mustard Gas | Mustard Gas results in decreased expression of PRKCB mRNA | 15674843 |
| D037742 | Nanotubes, Carbon | "Nanotubes, Carbon analog results in decreased expression of PRKCB mRNA" | 25554681 |
| D037742 | Nanotubes, Carbon | "Nanotubes, Carbon results in decreased expression of PRKCB mRNA" | 25554681 |
| D015058 | 1-Naphthylisothiocyanate | 1-Naphthylisothiocyanate results in increased expression of PRKCB mRNA | 25380136 |
| C005273 | naringenin | naringenin inhibits the reaction [Tetradecanoylphorbol Acetate affects the localization of PRKCB protein] | 25866363 |
| D009532 | Nickel | Nickel results in increased expression of PRKCB mRNA | 24768652|2558310 |
| C017557 | nickel subsulfide | nickel subsulfide affects the expression of PRKCB mRNA | 24952340 |
| D009538 | Nicotine | Nicotine affects the localization of PRKCB protein | 17003101 |
| C044387 | N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine | "N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [FCER1A protein affects the localization of PRKCB protein]" | 16818790 |
| C025589 | ochratoxin A | ochratoxin A metabolite results in increased expression of PRKCB mRNA | 26314263 |
| C025589 | ochratoxin A | ochratoxin A results in increased expression of PRKCB mRNA | 26314263 |
| C030110 | oxaliplatin | [oxaliplatin co-treated with Topotecan] results in decreased expression of PRKCB mRNA | 25729387 |
| C496932 | panobinostat | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRKCB mRNA" | 27188386 |
| C496932 | panobinostat | panobinostat results in increased expression of PRKCB mRNA | 26272509 |
| C076994 | perfluorooctane sulfonic acid | perfluorooctane sulfonic acid results in decreased expression of PRKCB protein | 19945530 |
| C023036 | perfluorooctanoic acid | perfluorooctanoic acid results in increased expression of PRKCB protein | 19945530 |
| C023036 | perfluorooctanoic acid | perfluorooctanoic acid results in decreased expression of PRKCB mRNA | 19162173 |
| C058305 | phenethyl isothiocyanate | phenethyl isothiocyanate results in decreased phosphorylation of and results in decreased expression of PRKCB protein | 26456889 |
| D010656 | Phenylephrine | Phenylephrine promotes the reaction [RBCK1 protein binds to PRKCB protein] | 17121852 |
| D010656 | Phenylephrine | Phenylephrine results in increased expression of PRKCB protein | 17121852 |
| D010656 | Phenylephrine | RBCK1 protein inhibits the reaction [Phenylephrine results in increased expression of PRKCB protein] | 17121852 |
| D010662 | Phenylmercuric Acetate | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PRKCB mRNA" | 27188386 |
| D010662 | Phenylmercuric Acetate | Phenylmercuric Acetate results in decreased expression of PRKCB mRNA | 26272509 |
| D010718 | Phosphatidylserines | Phosphatidylserines promotes the reaction [Chlordecone results in increased activity of PRKCB protein] | 1724372 |
| D010718 | Phosphatidylserines | Phosphatidylserines promotes the reaction [Dicofol results in increased activity of PRKCB protein] | 1724372 |
| D010862 | Pilocarpine | Pilocarpine results in increased expression of PRKCB protein | 18774262 |
| D010862 | Pilocarpine | Pilocarpine results in decreased expression of PRKCB mRNA | 17971868 |
| D010862 | Pilocarpine | Pilocarpine results in increased expression of PRKCB protein | 15058486 |
| D028321 | Plant Preparations | Plant Preparations results in decreased expression of PRKCB mRNA | 24973489 |
| C531249 | Poly(amidoamine) | Poly(amidoamine) analog results in increased expression of PRKCB mRNA | 23806026 |
| D011192 | Potassium Dichromate | Potassium Dichromate results in increased expression of PRKCB protein | 23718831 |
| D011285 | Pregnenolone Carbonitrile | Pregnenolone Carbonitrile results in decreased expression of PRKCB mRNA | 19162173 |
| D011374 | Progesterone | Progesterone results in decreased expression of PRKCB mRNA | 19690047 |
| C107773 | pterostilbene | pterostilbene inhibits the reaction [Azoxymethane results in increased phosphorylation of and results in increased activity of PRKCB protein] | 21355597 |
| D011794 | Quercetin | Quercetin results in decreased expression of PRKCB protein | 14750173 |
| D011794 | Quercetin | Quercetin results in decreased expression of PRKCB mRNA | 26076811 |
| D011794 | Quercetin | Quercetin inhibits the reaction [Cadmium Chloride results in decreased expression of PRKCB protein] | 27389774 |
| C012526 | quercitrin | quercitrin affects the expression of PRKCB mRNA | 25193878 |
| C059514 | resveratrol | resveratrol inhibits the reaction [Glucose results in increased activity of PRKCB protein] | 20578705 |
| C059514 | resveratrol | resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of PRKCB protein] | 24672638 |
| D019782 | Riluzole | Riluzole inhibits the reaction [VEGFA protein results in increased phosphorylation of PRKCB protein] | 16303979 |
| C089730 | rosiglitazone | PRKCB protein affects the susceptibility to rosiglitazone | 16672634 |
| C099154 | ruboxistaurin | ruboxistaurin results in decreased activity of PRKCB protein | 25634538 |
| C099154 | ruboxistaurin | ruboxistaurin inhibits the reaction [Glucose results in increased phosphorylation of and results in increased activity of PRKCB protein] | 19587355 |
| C099154 | ruboxistaurin | ruboxistaurin binds to and results in decreased activity of PRKCB protein | 20444914 |
| C099154 | ruboxistaurin | ruboxistaurin results in decreased activity of PRKCB protein | 17443133 |
| D012524 | Sarin | Sarin results in increased expression of PRKCB mRNA | 19522546 |
| C110822 | SDZ CPI 975 | SDZ CPI 975 results in decreased expression of PRKCB mRNA | 19234235 |
| C094089 | SDZ FOX 988 | SDZ FOX 988 results in decreased expression of PRKCB mRNA | 19234235 |
| D012643 | Selenium | Selenium results in decreased expression of PRKCB mRNA | 19244175 |
| D017632 | Asbestos, Serpentine | "Asbestos, Serpentine results in decreased expression of PRKCB mRNA" | 21148743 |
| D012822 | Silicon Dioxide | Silicon Dioxide analog affects the expression of PRKCB mRNA | 23806026 |
| C009277 | sodium arsenate | sodium arsenate results in increased expression of PRKCB mRNA | 21795629 |
| C017947 | sodium arsenite | sodium arsenite results in decreased expression of PRKCB protein | 24517892 |
| D012969 | Sodium Fluoride | Sodium Fluoride results in increased expression of PRKCB mRNA | 27862939 |
| C543528 | sotrastaurin | sotrastaurin inhibits the reaction [docetaxel results in increased phosphorylation of PRKCB protein] | 25634538 |
| C543528 | sotrastaurin | sotrastaurin results in decreased activity of PRKCB protein | 25634538 |
| D013311 | Streptozocin | Streptozocin results in increased phosphorylation of PRKCB protein | 16980342 |
| D004113 | Succimer | [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PRKCB mRNA | 26378955 |
| C016766 | sulforafan | sulforafan results in increased expression of PRKCB mRNA | 26833863 |
| D013481 | Superoxides | [Ethanol results in increased localization of and results in increased activity of PRKCB protein] promotes the reaction [Tetradecanoylphorbol Acetate results in increased abundance of Superoxides] | 10651808 |
| D013605 | T-2 Toxin | T-2 Toxin results in decreased expression of PRKCB mRNA | 26141394 |
| C061133 | tamibarotene | tamibarotene results in increased expression of PRKCB mRNA | 15498508 |
| D020002 | tert-Butyl Alcohol | tert-Butyl Alcohol inhibits the reaction [Thapsigargin results in increased localization of PRKCB protein] | 15843515 |
| D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin co-treated with Cycloheximide] results in increased expression of PRKCB mRNA | 19684285 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of PRKCB mRNA | 11007951|1968428 |
| D013749 | Tetrachlorodibenzodioxin | "PRKCB protein inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [CYP1B1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]]" | 10037446 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of PRKCB mRNA | 19465110 |
| D013749 | Tetrachlorodibenzodioxin | AHR protein affects the reaction [Tetrachlorodibenzodioxin affects the localization of PRKCB protein] | 16797713 |
| D013749 | Tetrachlorodibenzodioxin | alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin affects the localization of PRKCB protein] | 16797713 |
| D013749 | Tetrachlorodibenzodioxin | alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased localization of PRKCB protein] | 17222441 |
| D013749 | Tetrachlorodibenzodioxin | RACK1 protein affects the reaction [Tetrachlorodibenzodioxin affects the localization of PRKCB protein] | 16797713 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the localization of PRKCB protein | 16797713 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of PRKCB mRNA | 20959002 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased localization of PRKCB protein | 17222441 |
| D013755 | Tetradecanoylphorbol Acetate | [Ethanol results in increased localization of and results in increased activity of PRKCB protein] promotes the reaction [Tetradecanoylphorbol Acetate results in increased abundance of Superoxides] | 10651808 |
| D013755 | Tetradecanoylphorbol Acetate | naringenin inhibits the reaction [Tetradecanoylphorbol Acetate affects the localization of PRKCB protein] | 25866363 |
| D013755 | Tetradecanoylphorbol Acetate | PRKCB protein affects the reaction [Tetradecanoylphorbol Acetate affects the localization of Zinc] | 16495082 |
| D013755 | Tetradecanoylphorbol Acetate | PRKCB protein alternative form affects the reaction [Tetradecanoylphorbol Acetate results in increased expression of SOD2 mRNA] | 21705328 |
| D013755 | Tetradecanoylphorbol Acetate | resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of PRKCB protein] | 24672638 |
| D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate affects the localization of PRKCB protein | 15976015|1944785 |
| D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate affects the localization of PRKCB protein alternative form | 21705328 |
| D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate results in decreased expression of PRKCB protein | 18313772 |
| D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate results in decreased expression of PRKCB protein modified form | 15330761 |
| D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate results in decreased phosphorylation of PRKCB protein | 15380616 |
| D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate results in increased phosphorylation of PRKCB protein | 24672638 |
| D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate results in increased activity of PRKCB protein | 1724372 |
| D013755 | Tetradecanoylphorbol Acetate | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of PRKCB mRNA | 25613284 |
| D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate results in increased localization of PRKCB protein | 15843515 |
| D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate results in decreased phosphorylation of PRKCB protein | 15089098 |
| D013779 | Tetrodotoxin | [Bupivacaine co-treated with Tetrodotoxin co-treated with Dexamethasone] results in decreased expression of PRKCB mRNA | 22341215 |
| D019284 | Thapsigargin | Thapsigargin inhibits the reaction [EGF protein affects the localization of PRKCB protein] | 17991733 |
| D019284 | Thapsigargin | 1-Butanol inhibits the reaction [Thapsigargin results in increased localization of PRKCB protein] | 15843515 |
| D019284 | Thapsigargin | tert-Butyl Alcohol inhibits the reaction [Thapsigargin results in increased localization of PRKCB protein] | 15843515 |
| D019284 | Thapsigargin | Thapsigargin results in increased localization of PRKCB protein | 15843515 |
| D013804 | Thenoyltrifluoroacetone | Thenoyltrifluoroacetone inhibits the reaction [Glucose results in increased expression of PRKCB protein] | 16285992 |
| D013804 | Thenoyltrifluoroacetone | Thenoyltrifluoroacetone inhibits the reaction [Glucose results in increased expression of PRKCB protein alternative form] | 16285992 |
| D013827 | Thiabendazole | Thiabendazole results in increased expression of PRKCB mRNA | 18539377 |
| D013893 | Thiram | Thiram results in decreased activity of PRKCB protein | 15998240 |
| C080287 | thymeleatoxin | thymeleatoxin affects the localization of PRKCB protein | 9852137 |
| C009495 | titanium dioxide | titanium dioxide results in decreased expression of PRKCB mRNA | 27760801 |
| C009495 | titanium dioxide | titanium dioxide results in increased expression of PRKCB mRNA | 23557971 |
| D014050 | Toluene | Toluene affects the expression of PRKCB mRNA | 21827849 |
| D019772 | Topotecan | [oxaliplatin co-treated with Topotecan] results in decreased expression of PRKCB mRNA | 25729387 |
| D014212 | Tretinoin | Tretinoin promotes the reaction [arsenic trioxide results in increased expression of PRKCB mRNA] | 10673743 |
| D014212 | Tretinoin | Tretinoin results in increased expression of PRKCB mRNA | 15498508|1605412 |
| D014212 | Tretinoin | Tretinoin results in increased phosphorylation of PRKCB protein | 19476501 |
| D014212 | Tretinoin | Tretinoin results in increased phosphorylation of PRKCB protein | 19476501 |
| C011559 | tributyltin | tributyltin results in increased expression of PRKCB mRNA | 26314263 |
| C012589 | trichostatin A | trichostatin A results in increased expression of PRKCB mRNA | 24935251 |
| C057693 | troglitazone | troglitazone results in increased expression of PRKCB mRNA | 28973697 |
| D017974 | Uranium Compounds | Uranium Compounds results in decreased expression of PRKCB mRNA | 19654044 |
| D014580 | Ursodeoxycholic Acid | Ursodeoxycholic Acid results in increased activity of PRKCB protein | 7705931 |
| D014635 | Valproic Acid | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRKCB mRNA" | 27188386 |
| D014635 | Valproic Acid | Valproic Acid affects the expression of PRKCB mRNA | 25979313 |
| D014635 | Valproic Acid | Valproic Acid results in increased expression of PRKCB mRNA | 23179753|2438349 |
| D014639 | Vanadium | Vanadium results in decreased expression of PRKCB mRNA | 19000753 |
| D001335 | Vehicle Emissions | Vehicle Emissions results in decreased methylation of PRKCB gene | 25560391 |
| C029297 | vinylidene chloride | vinylidene chloride results in increased expression of PRKCB mRNA | 26682919 |
| C111237 | vorinostat | "[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRKCB mRNA" | 27188386 |
| C111237 | vorinostat | vorinostat results in increased expression of PRKCB mRNA | 26272509|2718838 |
| D015029 | Zeranol | ethyl-1-(4-(2*3*3-trichloroacrylamide)phenyl)-5-(trifluoromethyl)-1H-pyrazole-4-carboxylate inhibits the reaction [Zeranol results in increased phosphorylation of PRKCB protein] | 27224899 |
| D015029 | Zeranol | Zeranol results in increased phosphorylation of PRKCB protein | 27224899 |
| D015032 | Zinc | PRKCB protein affects the reaction [Tetradecanoylphorbol Acetate affects the localization of Zinc] | 16495082 |
| D015032 | Zinc | Zinc promotes the reaction [FCER1A protein affects the localization of PRKCB protein] | 16818790 |
| D015032 | Zinc | Zinc promotes the reaction [OPRM1 protein binds to PRKCB protein] | 18652891 |